Position in MGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$728,310
+$584,606 QoQ
Shares Held
53,909
+224.9% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 156 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,774,319 across 417 Biotechnology names. MGTX ranks #154 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in MGTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $728,310 | 53,909 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $143,704 | 16,594 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $395,814 | 49,788 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $224,736 | 27,307 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $149,640 | 22,951 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $165,594 | 24,424 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $143,657 | 23,589 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $62,028 | 14,875 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $62,901 | 14,941 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $66,569 | 10,967 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $67,532 | 9,620 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $37,777 | 7,694 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $94,489 | 14,061 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $34,308 | 6,636 | Shares | Defined | 2023-05-12 | |
| 2022-06-30 | $1,627 | 215 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $222,943 | 16,097 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $701,801 | 29,562 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $788,189 | 59,802 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,933 | 1,286 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $87,286 | 6,049 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $555,606 | 36,698 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $134,200 | 10,136 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $203,247 | 16,234 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $464,390 | 34,553 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||